Epstein-Barr Virus (EBV), Quantitative, DNA PCR, Whole Blood
Use
This test is intended to be used for the quantitative detection of Epstein-Barr virus (EBV) DNA and as an aid in the diagnosis and management of EBV infections.
Special Instructions
This test is currently not available in New York state.
Limitations
The quantitative range for this test is between 100 and 1,000,000 copies/mL. It is important to note that this test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA), as the FDA determined that such clearance or approval is not necessary. Additionally, the test is not suitable for frozen blood, heparin tube samples, improper labeling, gross specimen contamination, improper storage or transport, specimen too old, and leaking or broken tubes.
Methodology
PCR-based (Real-time PCR)
Biomarkers
LOINC Codes
- 36923-1
- 36923-1
- 53774-6
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
2 mL
Minimum Volume
0.6 mL
Container
Lavender-top (EDTA) or yellow-top (ACD) tube
Storage Instructions
Refrigerate.
Causes for Rejection
Frozen blood; heparin tube; improper labeling; gross specimen contamination; improper storage or transport; specimen too old; leaking or broken tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | Unstable |
Other tests from different labs that may be relevant